ACE-inhibition plus mineralocorticoid antagonism versus ACE-inhibition alone in patients with anterior myocardial infarction

Cardiovascular Drugs and Therapy

Volumn 15, Issue 4, 2001, Pages 309-314

  Di Pasquale, Pietro ^a   Cannizzaro, Sergio ^a   Scandurra, Angela ^b   Giubilato, Alfonso ^a   Scalzo, Sebastiano ^a   Paterna, Salvatore ^c  

^a Ospedale GF Ingrassia   (Italy)

^b Civic Hospital   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

Aldosterone; Canreonate; Cardiac volumes; Diastolic function; Echocardiography; Myocardial infarction

Indexed keywords

CANRENOIC ACID; CAPTOPRIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEART ENZYME; MINERALOCORTICOID ANTAGONIST; PLACEBO; POTASSIUM;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; ENZYME BLOOD LEVEL; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME;

AGED; ALDOSTERONE ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CANRENOATE POTASSIUM; CAPTOPRIL; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION;

EID: 0035212389     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012754514127     Document Type: Article

References (26)

1. Pathological hypertrophy and cardiac interstitium fibrosis and renin angiotensin aldosterone system
2. Aldosterone and antialdosterone therapy in congestive heart failure
3. Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension
4. Neointimal thickening after balloon denudation is enhanced by aldosterone and inhibited by spironolactone, an aldosterone antagonist
5. Evidence of partial escape of renin angiotensin aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors
6. Aldosterone escape during angiotensin converting enzyme inhibitor therapy in chronic heart failure
7. Effects of ramipril and spironolactone on ventricular remodeling after acute myocardial infarction: Randomized and double-blind study
8. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
9. Recommendations for quantification of left ventricle by two-dimensional echocardiography
10. The noninvasive assessment of left ventricular diastolic function with two-dimensional and doppler echocardiography
11. The EPHESUS Trial: Eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction
12. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression
13. Antihypertensive therapy with MK 421: Angiotensin II-renin relationship to evaluate efficacy of converting enzyme blockade
14. Escape of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: Implications for therapy
15. Effectiveness of spironolactone added to an angiotensin converting enzyme inhibitor and loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study (RALES)
16. Remodeling of rat right and left ventricles in experimental hypertension
17. Inverse relationship betwen aldosterone and artery compliance in chronically treated heart failure patients
18. Effects of adding spirolactone to an angiotension-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease
19. Neurosteroid biosynthesis: Gene for adrenal for steroidogenic enzymes are expressed in the brainb
20. Vascular aldosterone. Biosynthesis and a link to angiotensin II induced hypertrophy of vascular smooth muscle cells
21. Similarity bettween a substance produced by the heart in vitro and the 18-monoacetyl derivative of D-aldosterone
22. Myocardial production of aldosterone and corticosterone in rat. Physiological regulation
23. + dependent 11beta-hydroxy-steroid dehydrogenase in the human heart
24. Role of tissue renin in the regulation of aldosterone biosynthesis in the adrenal cortex of the nephrectomized rats
25. Activation of cardiac aldosterone production in rat myocardial infarction
26. Aldosterone and spironolactone in heart failure